Novel molecular-targeted therapeutics for the treatment of cancer

Hiroshi Yasui1, Kohzoh Imai

  • 1First Department of Internal Medicine, Sapporo Medical University, South 1, West 17, Chuo-ku, Sapporo, 060-0061, Japan.

Insights

Novel targeted cancer therapies are emerging, with over 30 agents in development. These therapies target molecular pathways and genetic alterations, showing significant efficacy in treating solid tumors and hematologic malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Intensive research has identified key molecular targets in cancer, including receptor tyrosine kinases, intracellular pathways, and genetic/epigenetic alterations.
  • This has led to a significant increase in the development of novel, targeted cancer therapies and treatment regimens.
  • Over 30 new agents are currently undergoing testing for solid tumors and hematologic malignancies.

Purpose of the Study:

  • To discuss the current understanding of the mechanisms of action for novel molecular targeted cancer therapies.
  • To review agents being investigated in preclinical and clinical settings.
  • To highlight therapies targeting cell surface receptors, intracellular signaling, and cell maintenance processes.

Main Methods:

  • Review of recent laboratory and preclinical studies.
  • Analysis of ongoing clinical trials for novel targeted agents.
  • Discussion of mechanisms of action for various targeted therapies.

Main Results:

  • Identification and validation of numerous therapeutic molecular targets in cancer.
  • Development of over 30 novel targeted agents showing significant efficacy.
  • Demonstrated prolonged survival in patients treated with these novel agents.

Conclusions:

  • Novel molecular targeted therapies represent a promising advancement in cancer treatment.
  • These therapies target specific molecular pathways and alterations, leading to improved patient outcomes.
  • Ongoing research continues to expand the landscape of targeted cancer therapeutics.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...